The elevated levels of both CD4+ and CD8+ T cells in the low‐mPCDS group suggest that these patients benefit from a well‐orchestrated immune surveillance system, which may help in controlling tumour growth more effectively. The gene discussed is CD8A; the disease is neoplasm.